21
Nov 2023
UK approves gene-editing drug for sickle cell disease
Medical regulators in the UK have approved a gene therapy that aims to cure two blood disorders. The treatment for sickle cell disease and beta thalassemia is the first to be licensed using the gene-editing tool known as Crispr, a revolutionary advance for two inherited blood conditions, both triggered by errors in the gene…